跳至主要内容
临床试验/EUCTR2011-006086-17-ES
EUCTR2011-006086-17-ES进行中(未招募)不适用

Effectiveness of homeopathic treatment (Agraphis nutans 5CH, Thuya occidentalis 5CH, Kalium muriaticum and Arsenicum iodatum 9CH 9CH) as adjuvant secretory otitis in children

Maria Fernanda Pedrero Escalas0 个研究点开始时间: 2012年2月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age: 2 months - 12 years
  • - Informed consent from parents / guardians
  • - OS unilateral or bilateral consultations ENT diagnosed with pneumatic otoscopy as the presence or absence of tympanic mobility. Each ear will count as one unit primary endpoint.
  • - Not following any standard treatment, namely mainly steroids, antihistamines and mucolytics.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 220
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - AOM or complicated at the time of baseline
  • - Not have passed the newborn hearing screenig (OAE)
  • - Concomitant diseases,
  • - Sensorineural hearing loss permanent
  • - Down Syndrome or other craniofacial malformations,
  • - Malformations of the outer or middle ear
  • - Acute Mastoiditis and Cholesteatoma
  • - Vaccination recent (less than 30 days)
  • - Cilial motility disorders (Kartagener syndrome)
  • - Language Alterations or prelingual speech
  • - Prior Adenoidectomy
  • - Persistence of DTT or perforated eardrum
  • - Lactose intolerance or diabetes (incompatible with placebo and homeopathy)

研究者

发起方
Maria Fernanda Pedrero Escalas

相似试验